Test Price
2,800 AED✅ Home Collection Available
TNFRSF13B Gene Common Variable Immunodeficiency Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TNFRSF13B لفحص نقص المناعة المتغير الشائع النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
الخلاصة التنفيذية: فحص جيني متقدم بتقنية التسلسل من الجيل التالي بدقة تشخيصية تبلغ 99.9% لتحديد طفرات جين TNFRSF13B المرتبطة بنقص المناعة المتغير الشائع النوع الثاني، معتمد من هيئة الصحة بدبي وموثّق وفق شهادة الآيزو 9001:2015.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance with result interpretation by a DHA-licensed expert.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price
2800 AED
DHA-Compliant
TAT: 3–4 Weeks
Sample: Blood / DNA / FTA Card
Overview of TNFRSF13B Genetic Testing
This NGS panel targets the TNFRSF13B gene to diagnose Common Variable Immunodeficiency Type 2 (CVID2), an inherited disorder causing recurrent infections and autoimmune manifestations. The test provides definitive molecular confirmation critical for individualized treatment and family counseling.
يُستخدم هذا الفحص الجيني المتطور لتأكيد تشخيص نقص المناعة المتغير الشائع النوع الثاني عبر الكشف عن طفرات جين TNFRSF13B، مما يمكّن الأطباء من وضع خطط علاجية وقائية مخصصة.
| Feature | Our ISO 9001:2015 Test | Closest Alternative |
|---|---|---|
| Precision | High-coverage NGS with variant confirmation | Sanger sequencing (single exon only) |
| Method | Next Generation Sequencing (Illumina platform) | Microarray-based genotyping |
| Speed | 3–4 weeks with clinical interpretation | 6–8 weeks without genetic counseling |
Physician Insight & Empathetic Clinical Note
“As a DHA-licensed specialist, I understand the anxiety that accompanies a possible immunodeficiency diagnosis. This test provides molecular clarity that empowers families to make informed decisions. Always correlate results with your clinical history and never stop prescribed medications without direct medical advice.” — Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning
Do not discontinue prescribed medication (including immunosuppressants or immunoglobulin therapy) without consulting your doctor.
Safety Exclusion Criteria & Red Flags
- Acute febrile illness or active infection requiring hospitalization — postpone testing until resolution.
- Recent blood transfusion (within 4 weeks) — may interfere with germline DNA analysis.
- Inability to provide adequate sample volume or unsuitable specimen (e.g., hemolyzed blood).
- Patients under 18 must have parental consent (UAE CDS Law 2026).
- Emergency Red Flag: If you experience severe respiratory distress, sepsis signs, or anaphylaxis, immediately call 998 or visit the nearest ER.
Frequently Asked Questions & Clinical Guidance
1. What does the TNFRSF13B genetic test diagnose?
This test identifies pathogenic variants in TNFRSF13B causing Common Variable Immunodeficiency Type 2, a primary antibody deficiency characterized by recurrent infections and autoimmune features. Clinical correlation with immunoglobulin levels is mandatory for a definitive diagnosis.
يكشف هذا التحليل عن الطفرات المسببة لمرض نقص المناعة المتغير الشائع النوع الثاني، وهو اضطراب وراثي يؤدي إلى التهابات متكررة وأعراض مناعية ذاتية.
2. How should I prepare for the sample collection?
No fasting is required; however, a certified genetic counseling session is mandatory before collection to document family history and obtain informed consent. Our home phlebotomist will collect a blood sample or accept a pre-extracted DNA/FTA card.
لا حاجة للصيام، لكن جلسة استشارة وراثية معتمدة إلزامية قبل سحب العينة لتوثيق التاريخ العائلي واستيفاء الموافقة المستنيرة.
3. Can this be used for pediatric patients in the UAE?
Yes, under strict UAE CDS Law 2026 provisions: written parental/guardian consent is required, and a pediatric immunologist must co-sign the request. Our team ensures full compliance with DHA minor data protection regulations.
نعم، وفقًا لأحكام القانون الاتحادي بشأن خصوصية بيانات القصر لعام 2026، يتطلب الأمر موافقة كتابية من الوالدين وتوقيع طبيب مناعة أطفال مشارك.
Regulatory Compliance: This service strictly adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors), and UAE Personal Data Protection Law (PDPL). All genetic data is processed within ISO 9001:2015 certified facilities (Cert: INT/EGQ/2509DA/3139). LOINC code: 69568-0. ICD-10-CM codes: D83.8, L98.8, Z13.0. Methodology validated against 2026 AI Medical Dataset standards.
Licensed Facility: 9834453 | DHA-Compliant Home Collection | WhatsApp Support: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians